{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:04Z","timestamp":1790803264615,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000151","name":"Canadian Federation of University Women","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jcjo.2025.04.005","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T22:07:59Z","timestamp":1749161279000},"page":"330-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of ocular manifestations in cutaneous rosacea: systematic review and meta-analysis"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9949-7253","authenticated-orcid":false,"given":"Ryan H.","family":"Kirkpatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1084-9865","authenticated-orcid":false,"given":"Kristina","family":"Nazzicone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2552-1438","authenticated-orcid":false,"given":"Aleksandar","family":"Biorac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3700-1195","authenticated-orcid":false,"given":"Anneke R.","family":"Froentjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9383-034X","authenticated-orcid":false,"given":"Sonja","family":"Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2025.04.005_bib0001","first-page":"282","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Brit J Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0002","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jaad.2018.08.049","article-title":"Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: Review and clinical practice experience","volume":"80","author":"Alexis","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0003","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40257-021-00595-7","article-title":"Rosacea: new concepts in classification and treatment","volume":"22","author":"van Zuuren","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0004","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","article-title":"Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0005","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1159\/000522494","article-title":"Ocular symptoms and rosacea: a population-based study","volume":"238","author":"Sinikumpu","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0006","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jcjo.2021.02.034","article-title":"Retrospective analysis of ophthalmology referrals during the COVID-19 pandemic compared to prepandemic","volume":"56","author":"Schlenker","year":"2021","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0007","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0039-6257(86)90034-2","article-title":"Ocular rosacea","volume":"31","author":"Browning","year":"1986","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0008","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00003226-200304000-00009","article-title":"The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics","volume":"22","author":"Ghanem","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0009","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00003226-199503000-00005","article-title":"Meibomian gland dysfunction and tear film abnormalities in rosacea","volume":"14","author":"Zengin","year":"1995","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0010","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0011","article-title":"Prevalence of ocular manifestations in cutaneous rosacea: Protocol for a systematic review and meta-analysis","volume":"2024","author":"Nazzicone","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0012","unstructured":"Veritas Health Innovation. Covidence systematic review software. Melbourne, Australia 2024."},{"key":"10.1016\/j.jcjo.2025.04.005_bib0013","series-title":"Chapter 5: Systematic reviews of prevalence and incidence","year":"2020"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0015","series-title":"R: A language and environment for statistical computing","year":"2021"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13690-023-01215-y","article-title":"Methods for meta-analysis and meta-regression of binomial data: concepts and tutorial with Stata command metapreg","volume":"82","author":"Nyaga Victoria","year":"2024","journal-title":"Arch Public Health"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0018","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0019","first-page":"9","article-title":"Oculocutaneous aspects of rosacea","volume":"62","author":"Starr","year":"1969","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0020","series-title":"Grading of recommendations assessment, development and evaluation","author":"Schumemann","year":"2013"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0021","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jaad.2016.08.055","article-title":"Prevalence and risk of migraine in patients with rosacea: A population-based cohort study","volume":"76","author":"Egeberg","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0022","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/1346-8138.16317","article-title":"Characterization of rosacea patients in Tohoku area of Japan: retrospective study of 340 rosacea cases","volume":"49","author":"Wada-Irimada","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0023","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5021\/ad.2009.21.3.243","article-title":"Clinical evaluation of 168 Korean patients with rosacea: the sun exposure correlates with the erythematotelangiectatic subtype","volume":"21","author":"Bae","year":"2009","journal-title":"Annals Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0024","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12385","article-title":"An observational cross-sectional survey of rosacea: Clinical associations and progression between subtypes","volume":"169","author":"Tan","year":"2013","journal-title":"Brit J Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/09546634.2018.1468069","article-title":"Dose, duration, and cost: opportunities to improve use of long-term oral antibiotics for people with rosacea","volume":"30","author":"Rill","year":"2019","journal-title":"J Dermatol Treat"},{"issue":"3 Suppl. 1","key":"10.1016\/j.jcjo.2025.04.005_bib0026","first-page":"AB39","article-title":"A case-control study of rosacea subjects compared to control subjects","volume":"60","author":"Kazanis","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0027","first-page":"WC09","article-title":"Ocular manifestations in patients diagnosed with rosacea: a cross-sectional study from a tertiary care centre in northern India","volume":"16","author":"Sharma","year":"2022","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14733","article-title":"Carotid intima-media thickness and serum proinflammatory cytokine levels in rosacea patients without cardiovascular risk factors","volume":"34","author":"Ertekin","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0029","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1468-3083.2011.03995.x","article-title":"Clinical and laboratory study of ocular rosacea in northern Greece","volume":"25","author":"Lazaridou","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.5114\/ada.2018.76228","article-title":"Advanced oxidation protein products and serum total oxidant\/antioxidant status levels in rosacea","volume":"35","author":"Erdogan","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjo.2025.04.005_bib0031","first-page":"S100","article-title":"Rosacea is associated with chronic systemic inflammatory diseases in a skin severity-dependent manner","volume":"134","author":"Rainer","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0032","first-page":"9798","article-title":"Follicular scales, scalp and ocular involvement in patients with papulopustular rosacea: prevalence and association with Demodex mite proliferation","volume":"16","author":"Trave","year":"2024","journal-title":"Dermatol Rep"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0033","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/jocd.16094","article-title":"Evaluation of atherosclerotic risk in rosacea patients through serum fetuin-A and carotid intima media thickness","volume":"23","author":"Kulakl\u0131","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0034","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5935\/0004-2749.20200016","article-title":"Ocular surface changes in the treatment of rosacea: comparison between low-dose oral isotretinoin and doxycycline","volume":"83","author":"Andrade","year":"2020","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0035","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2133.1953.tb13184.x","article-title":"The ocular manifestations of rosacea","volume":"65","author":"Goldsmith","year":"1953","journal-title":"Brit J Dermatol (1951 Print)"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0036","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1994.01690030091015","article-title":"Rosacea: pathophysiology and treatment","volume":"130","author":"Wilkin","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0037","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0038","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4274\/tjo.galenos.2021.05031","article-title":"Association between skin findings and ocular signs in rosacea","volume":"51","author":"Sa\u00e1","year":"2021","journal-title":"Turkish J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0039","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3390\/jcm10132897","article-title":"Ocular comorbidities in rosacea: a case-control study based on seven institutions","volume":"10","author":"Woo","year":"2021","journal-title":"J Clin Med [Internet]"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jtos.2012.04.003","article-title":"Glycomic analysis of tear and saliva in ocular rosacea patients: the search for a biomarker","volume":"10","author":"Vieira","year":"2012","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0041","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archdermatol.2007.50","article-title":"Cutaneous and ocular signs of childhood rosacea","volume":"144","author":"Chamaillard","year":"2008","journal-title":"Arch Dermatol"},{"issue":"3 Suppl","key":"10.1016\/j.jcjo.2025.04.005_bib0042","first-page":"S79","article-title":"Dry eye disease: pathophysiology, classification, and diagnosis","volume":"14","author":"Perry","year":"2008","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0043","doi-asserted-by":"crossref","first-page":"2021-11-1","DOI":"10.7573\/dic.2021-11-1","article-title":"Dermatology: how to manage rosacea in skin of colour","volume":"11","author":"Maliyar","year":"2022","journal-title":"Drugs Context"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0044","article-title":"Prevalence and treatment of ocular rosacea based on retrospective analysis of out-patients","volume":"12","author":"Jakstaite","year":"2020","journal-title":"J Dermatol Nurses Assoc"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0045","first-page":"597","article-title":"Rosacea: 244 Tunisian cases","volume":"88","author":"Khaled","year":"2010","journal-title":"Tunisie Medicale"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0046","first-page":"20","article-title":"Frequency, severity and treatment of ocular rosacea during cutaneous rosacea","volume":"130","author":"Michel","year":"2003","journal-title":"Annal Dermatol Venereol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0047","first-page":"544","article-title":"Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline","volume":"8","author":"Arman","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0048","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2009.03132.x","article-title":"Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin","volume":"23","author":"Bakar","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0049","doi-asserted-by":"crossref","first-page":"AB34","DOI":"10.1016\/j.jaad.2019.06.162","article-title":"Combined doxycycline 40 mg modified release capsules plus ivermectin 1% cream therapy for severe papulopustular rosacea","volume":"81","author":"Del Rosso","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0050","first-page":"47","article-title":"Diagnostic indicators of rosacea and demodicosis","volume":"99","author":"Forton","year":"2018","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0051","first-page":"1190","article-title":"Ocular manifestations in rosacea: A clinical study","volume":"16","author":"Gupta","year":"2024","journal-title":"Int J Pharm Clin Res"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0052","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/jdv.12556","article-title":"Decreased serum paraoxonase and aryl esterase activities in patients with rosacea","volume":"29","author":"Takci","year":"2015","journal-title":"J Euro Acad Dermatol Venereol"},{"key":"10.1016\/j.jcjo.2025.04.005_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1026447","article-title":"Clinical characteristics of combined rosacea and migraine","volume":"9","author":"Wienholtz","year":"2022","journal-title":"Front Med"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418225001565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418225001565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T22:40:38Z","timestamp":1764628838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418225001565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0008418225001565"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.04.005","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of ocular manifestations in cutaneous rosacea: systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Canadian Ophthalmological Society.","name":"copyright","label":"Copyright"}]}}